Table of Contents

January 01, 2024; Volume 91, Issue 1

  • From the Editor

      • It’s a new year, looking back and looking forward

        Brian F. Mandell, MD, PhD
        • Cleveland Clinic Journal of Medicine January 2024, 91 (1) 15-16;
        • DOI: https://doi.org/10.3949/ccjm.91b.01024

        • Reflections on highlights from 2023 and impending changes in 2024, along with some acknowledgments and farewells.

  • The Clinical Picture

      • Conjunctival petechiae in infective endocarditis

        Akinori Sekizawa, MD, Ayaka Nagano, MD, Kenichi Hashimoto, MD, PhD and Yosuke Ono, MD, PhD
        • Cleveland Clinic Journal of Medicine January 2024, 91 (1) 20-21;
        • DOI: https://doi.org/10.3949/ccjm.91a.23041

        • A 75-year-old-man presented with a 33-day history of intermittent nocturnal fevers of 39°C (102°F) and truncal rashes. The rashes appeared on the same day as the fever.

  • Review

      • TOC Icon

        Consumer-grade wearable cardiac monitors: What they do well, and what needs work

        Abdilahi Mohamoud, MBBS, Joseph Jensen, MD and Kevin G. Buda, DO
        • Cleveland Clinic Journal of Medicine January 2024, 91 (1) 23-29;
        • DOI: https://doi.org/10.3949/ccjm.91a.23030

        • The authors review common consumer-grade wearables, including the accuracy of these monitors compared with medical-grade devices, and present an approach to managing rate or rhythm abnormalities identified on at-home monitoring.

  • Editorial

      • Wearable cardiac monitors: Where do we stand?

        Jakub Sroubek, MD, PhD
        • Cleveland Clinic Journal of Medicine January 2024, 91 (1) 31-32;
        • DOI: https://doi.org/10.3949/ccjm.91a.23081

        • Wearable monitors perform well as screening tools for atrial fibrillation, but questions remain: Can they help with stroke prevention, what is their role in patients with known atrial fibrillation, and how do we streamline interpretation?

  • Review

      • Gastric intestinal metaplasia and gastric cancer prevention: Watchful waiting

        Shrouq Khazaaleh, MD, Mohammad Alomari, MD, Mamoon Ur Rashid, MD, Daniel Castaneda, MD and Fernando J. Castro, MD
        • Cleveland Clinic Journal of Medicine January 2024, 91 (1) 33-39;
        • DOI: https://doi.org/10.3949/ccjm.91a.23015

        • Malignancy develops in only a small minority of patients with gastric intestinal metaplasia. Recognition of clinical, endoscopic, and histologic features linked with cancer development is critical to identifying patients who require endoscopic surveillance.

      • 2023 Update in ambulatory general internal medicine

        Jason T. Alexander, MD, Simran K. Singh, MD, Sachin D. Shah, MD, Brianna Lambert, MD and Jeremy P. Smith, MD
        • Cleveland Clinic Journal of Medicine January 2024, 91 (1) 40-46;
        • DOI: https://doi.org/10.3949/ccjm.91a.23056

        • Topics reviewed include prevention of chronic kidney disease progression, diet for preventing secondary cardiovascular disease, prevention of kidney-stone recurrence, drug therapy for weight loss, and cholesterol management.

  • 1-Minute Consult

      • When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?

        Osamah Z. Badwan, MD, Lorenzo Braghieri, MD, Warren Skoza, MD, Ankit Agrawal, MD, Venu Menon, MD and W. H. Wilson Tang, MD
        • Cleveland Clinic Journal of Medicine January 2024, 91 (1) 47-51;
        • DOI: https://doi.org/10.3949/ccjm.91a.23034

        • Evidence from clinical trials supports starting these medications as early as possible in patients hospitalized with acute decompensated heart failure who do not have clear contraindications to them.

  • Current Drug Therapy

  • Letter to the Editor

PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine

Cleveland Clinic Journal of Medicine

Vol. 91, Issue 1

1 Jan 2024

Table of Contents Table of Contents (PDF) Index by author Complete Issue (PDF)

Issue highlights

Sign up for alerts

Jump to

More...
More...